MedTech News
.................... by Andrew Celentano
Bile acid buildup drives spread of breast cancer, discovery reveals
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of Virginia Comprehensive Cancer Center research reveals. The findings could open the door to new ways to prevent breast cancer metastasis (spread), improve patient outcomes and save lives.
The invisible wearable: New skin sensors advance health monitoring
While wearable health sensors are becoming increasingly common, current iterations are awkward to wear. For example, devices attached to the face can draw unwanted attention, increase self-consciousness and influence the signals users are trying to measure. However, recent research may have found a solution by introducing ultrathin sensors that cannot be seen by observers or felt by the wearer.
New tool makes immune therapy more effective in prostate cancer
Prostate cancer is often resistant to immunotherapy, which harnesses a person’s immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy new life, improving its ability to unleash cancer-killing cells in laboratory studies.
ElectroWire Medical Receives 510(k) Clearance for LightningWire™ Transseptal Puncture System
LEXINGTON, S.C., July 15, 2026 /PRNewswire/ — ElectroWire Medical announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its LightningWireTM Transseptal Puncture System, which is indicated to create an atrial septal defect in the heart, whereby various cardiovascular catheters are introduced.
SpinaFX Medical Receives CE Mark MDR Certification for its Triojection® System
TORONTO, July 15, 2026 /PRNewswire/ — SpinaFX Medical Inc. (“SpinaFX”), a Toronto‑based medical device company specializing in image‑guided, minimally invasive spine care, today announced it has received Medical Device Regulation (MDR) CE Mark certification for its Triojection® System (MDR 843778).
Blood-Vessel-on-a-Chip Models Can Now Grow and Redirect New Capillaries
Learn how mechanical stretching helped lab-grown vessels sprout and redirect new capillaries, a step toward keeping engineered tissues alive.
New cancer drug shows promise in mesothelioma trial
Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later. Worldwide, about 30,000 people are diagnosed with mesothelioma each year.
Two-isotope imaging could guide targeted alpha therapy for metastatic prostate cancer
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the advanced stages of the disease still requires more precise tools. Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have now tested a novel approach.